Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Harness the capabilities of artificial intelligence to accelerate the transition from laboratory research and experimental findings to the introduction of transformative therapies. Achieve a remarkable increase in research efficiency, potentially improving productivity by as much as 90% by cutting down your literature review time from several months to mere minutes. Eliminate distractions and enhance your search capabilities with a precise and accurate tool that simplifies the navigation of the expanding landscape of scientific publications. This approach not only saves time but also minimizes bias and enhances the likelihood of discovering groundbreaking insights. Delve deeply into the intricacies of disease biology and engage in sophisticated target identification. Causaly's advanced knowledge graph integrates data from countless publications, enabling thorough and objective scientific investigations. Effortlessly explore the intricate biological cause-and-effect dynamics without requiring extensive expertise. Access a comprehensive array of scientific documents and reveal previously overlooked connections. Causaly’s robust AI system processes millions of biomedical articles, facilitating improved decision-making and enhancing research outcomes, ultimately leading to a more informed and innovative scientific community. By utilizing such tools, researchers can significantly transform their methodologies and enhance their contributions to medicine.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
API Access
Has API
Integrations
Google Cloud Platform
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Causaly
Founded
2018
Country
United Kingdom
Website
www.causaly.com
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/